|1.||Kim, Dong-Hyun: 5 articles (02/2013 - 03/2004)|
|2.||You, Zhimei: 3 articles (10/2014 - 06/2014)|
|3.||Xia, Jing: 3 articles (10/2014 - 06/2014)|
|4.||Li, Jing: 3 articles (10/2014 - 06/2014)|
|5.||Li, Danyang: 3 articles (10/2014 - 06/2014)|
|6.||Chen, Dilong: 3 articles (10/2014 - 06/2014)|
|7.||Jin, Ying-Hua: 3 articles (03/2014 - 10/2011)|
|8.||Li, Yang: 3 articles (03/2014 - 10/2011)|
|9.||Ryu, Jong Hoon: 3 articles (12/2004 - 03/2004)|
|10.||Guo, Wenchang: 2 articles (04/2015 - 06/2014)|
01/01/2005 - "Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs."
01/01/2015 - "Ginsenoside Rh2 (GRh2) has been shown to significantly inhibit growth of some types of cancers, whereas its effects on the SCC have not been examined. "
12/01/2014 - "In addition, their activities were evaluated by eight different human tumor cells, compared with ginsenoside Rh2 group. "
12/01/2014 - "Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2."
10/01/2014 - "The effect of ginsenoside Rh2 on cancer is marked and ginsenoside Rh2 has been shown to inhibit pancreatic tumor migratory ability. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
02/28/2011 - "Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53."
02/28/2011 - "In this study, we showed that the ginsenoside Rh2 exhibited significantly more potent cell death activity than the ginsenoside Rg3 in HCT116 and SW480 colorectal cancer cells. "
01/01/2016 - "Combined Effect of Sodium Selenite and Ginsenoside Rh2 on HCT116 Human Colorectal Carcinoma Cells."
01/01/2016 - "Sodium selenite and ginsenoside Rh2 combination may be a more effective treatment for human colorectal carcinoma and is a promising chemotherapeutic approach for malignant tumors."
|3.||Breast Neoplasms (Breast Cancer)
05/01/1999 - "Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells."
01/01/2011 - "This study was undertaken to gain insights into the molecular mechanisms of ginsenoside Rh2 (Rh2)-induced cell death in human breast cancer cell lines as well as in in vivo xenografts. "
10/01/2009 - "Present study was undertaken to gain insights into the mechanism of cell cycle arrest by ginseng saponin ginsenoside Rh2 (Rh2) using MCF-7 and MDA-MB-231 breast cancer cells. "
01/01/2015 - "Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer."
|4.||Melanoma (Melanoma, Malignant)
01/01/1994 - "Recent studies indicate that ginsenoside Rh2 is an inducer of cell differentiation in melanoma B-16 cells in vitro. "
04/01/2010 - "On the model of transferred melanoma B-16, ginsenoside Rh2 showed a tendency to increase the antiblastome effect of the cytostatic drug."
04/01/2002 - "Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells."
12/01/2010 - "Cholesterol-dependent induction of dendrite formation by ginsenoside Rh2 in cultured melanoma cells."
10/01/2014 - "In the present study, Transwell chambers were used in order to investigate whether ginsenoside Rh2 inhibits the migratory ability of HepG2 liver carcinoma cells. "
10/01/2005 - "To investigate the effects of ginsenoside Rh2 (GS-Rh2) on growth inhibition and cell cycle of Eca-109 esophageal carcinoma cell line in culture. "
10/01/2014 - "Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors."
|1.||Sodium Selenite (Selenite)
|9.||Epidermal Growth Factor Receptor (EGF Receptor)
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)